Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:WTM
NYSE:WTMInsurance

Why White Mountains Insurance Group (WTM) Is Up 6.8% After Surging Q4 Profitability And EPS Turnaround

White Mountains Insurance Group reported fourth-quarter 2025 revenue of US$1,603.8 million and net income of US$835.8 million, reversing a year-earlier loss and lifting earnings per share from a loss of US$50.78 to profit of US$327.23. For the full year 2025, revenue rose to US$3.74 billion and net income to US$1.11 billion, with earnings per share from continuing operations increasing from US$89.79 to US$430.14, highlighting a very large improvement in profitability. We’ll now examine how...
NasdaqGM:RUM
NasdaqGM:RUMInteractive Media and Services

Rumble (RUM) Valuation Check As Rumble Shorts Launch Targets Higher Engagement And Monetization

Rumble Shorts launch and why it matters for Rumble stock Rumble (RUM) has launched Rumble Shorts, a short form vertical video feed on the web, with mobile rollout pending app store approvals. This gives investors a fresh product to consider. The new format lets users swipe through videos of 90 seconds or less, tip creators through Rumble Wallet, and discover channels more easily. These features could influence how investors evaluate engagement and monetization potential. See our latest...
NasdaqGS:COIN
NasdaqGS:COINCapital Markets

Is Coinbase (COIN) Turning Security Intelligence Into Its Core Competitive Edge In Crypto Infrastructure?

In late January 2026, Crypto ISAC and Coinbase announced an expanded integration that enables continuous, high-confidence sharing of Coinbase-sourced threat intelligence with the Crypto ISAC member community to help identify, disrupt, and mitigate sophisticated crypto-related attacks without exposing Coinbase customer data. This move highlights how Coinbase is positioning itself as a security-focused infrastructure partner, using automated, standards-based intelligence sharing to bolster...
NYSE:LMND
NYSE:LMNDInsurance

Is Lemonade (LMND) Using Tesla-Focused Autonomy Insurance To Redefine Its Long-Term Competitive Moat?

Lemonade recently launched autonomous car insurance tailored to Tesla vehicles equipped with Full Self-Driving, extending its AI-driven platform into a new corner of the auto market. This move deepens Lemonade’s push to pair advanced automation with insurance underwriting, while also supporting its broader ambitions for product and geographic expansion. Next, we’ll explore how entering Tesla’s autonomous insurance space could influence Lemonade’s investment narrative and long-term business...
NasdaqGS:ZBIO
NasdaqGS:ZBIOBiotechs

Does Zenas BioPharma (ZBIO) CEO’s Million‑Dollar Share Buy Reframe Management Credibility After Recent Setbacks?

Zenas BioPharma recently disclosed that CEO Lonnie Moulder purchased over US$1,000,000 of company shares after earlier disappointment over Phase 3 INDIGO results for obexelimab in Immunoglobulin G4-Related Disease and the announcement of a securities investigation by Pomerantz LLP. This combination of adverse clinical and legal headlines followed by a sizable insider buy has sharpened investor focus on management’s conviction and the future of Zenas’s autoimmune pipeline. We’ll now examine...
NasdaqGS:GT
NasdaqGS:GTAuto Components

Is It Time To Reassess Goodyear Tire & Rubber (GT) After Its Recent Share Price Rise?

If you are wondering whether Goodyear Tire & Rubber's current share price reflects its true worth, you are not alone. Many investors are asking if the recent moves are justified by underlying value. The stock last closed at US$10.54, with returns of 12.0% over 7 days, 14.2% over 30 days, 18.2% year to date and 25.5% over the past year, while the 3 year and 5 year returns stand at a 2.9% decline and a 25.1% decline respectively. Recent price action has put a spotlight on how the market...
NYSE:WST
NYSE:WSTLife Sciences

Is It Time To Revisit West Pharmaceutical Services (WST) After Recent Share Price Rebound?

If you are wondering whether West Pharmaceutical Services is fairly priced or offering value right now, looking at a clear, structured view of its valuation can help you decide how it fits into your watchlist. The share price closed at US$248.95, with a 7.7% gain over the last 7 days, while the 1 year return sits at a 22.3% decline and the year to date return is a 9.9% decline. Over the past month, the stock recorded a 9.6% decline, and over 3 and 5 year periods the returns are 7.4% and...
NYSE:UTZ
NYSE:UTZFood

Is Utz Brands (UTZ) Pricing Look Attractive After Multi‑Year Share Price Decline

If you are wondering whether Utz Brands at around US$10.98 is a bargain or fairly priced, this article will walk you through what the current share price might be implying. The stock has posted a 4.2% return over the last week and 10.5% over the last month, although it still shows a 6.7% return year to date and a 16.2% decline over the last year, extending to a 29.1% decline over three years and 53.6% over five years. Recent coverage of Utz Brands has focused on the company as a listed snack...
NYSE:PPG
NYSE:PPGChemicals

Why PPG Industries (PPG) Is Up 9.4% After Profit Rebound And Exclusive QCG Coatings Deal

PPG Industries recently reported past fourth-quarter 2025 results showing higher sales of US$3,914 million and a shift from a net loss to net income of US$300 million, alongside securing a sole-supplier refinish coatings agreement with Quality Collision Group’s more than 95 repair centers. Together with new 2026 earnings guidance and the launch of its UL 263-certified, low-VOC PPG STEELGUARD 652 fire protection coating, the company is emphasizing higher-margin technologies and deeper...
NYSE:CVNA
NYSE:CVNASpecialty Retail

Assessing Carvana (CVNA) Valuation After Strong Q3 2025 Results And Confident Growth Guidance

Carvana (CVNA) is back in focus after reporting a strong Q3 2025, with higher retail units sold, revenue growth, and record operating income. This performance has led management to offer confident guidance for Q4. See our latest analysis for Carvana. The Q3 update and the recent expansion of same day delivery into the Eugene area come against a backdrop of a volatile share price, with a 25.25% 90 day share price return but a 12.83% decline over 30 days, while total shareholder return over the...
TSE:8306
TSE:8306Banks

MUFG FX Views On ECB And UK Politics And Earnings Impact

MUFG's research team has highlighted changing expectations in currency markets ahead of the next European Central Bank policy meeting. Analysts at Mitsubishi UFJ Financial Group, TSE:8306, are assessing how possible ECB rate cuts, in response to slower inflation, are influencing views on the euro. The team is also examining how recent UK political tensions are feeding into sterling moves and short term trading sentiment. Mitsubishi UFJ Financial Group, TSE:8306, is a major global financial...
NasdaqGS:FORM
NasdaqGS:FORMSemiconductor

FormFactor (FORM) Valuation Check After Record Results And Strong AI Test Demand Guidance

FormFactor (FORM) has drawn fresh attention after releasing record fourth quarter and full year 2025 results, with earnings and revenue ahead of expectations and guidance that points to meaningfully higher first quarter 2026 revenue. See our latest analysis for FormFactor. The earnings beat and upbeat guidance appear to have reset expectations, with FormFactor’s 1 day share price return of 7.65% and 90 day share price return of 68.61% pointing to strong momentum. The 1 year total shareholder...
NasdaqGS:FFBC
NasdaqGS:FFBCBanks

First Financial Bancorp (FFBC) Is Up 7.5% After Record Fee Income And Shelf Offering News – Has The Bull Case Changed?

First Financial Bancorp. recently reported its fourth quarter and full-year 2025 results, showing higher net interest income year on year and full-year net income of US$255.61 million, while also affirming a US$0.25 quarterly dividend and reducing net charge-offs compared with the prior year period. Alongside these results, the bank filed a US$79.29 million shelf registration for 2,753,094 common shares and continued integrating the Westfield acquisition, which boosted deposits and fee...
NYSE:TWO
NYSE:TWOMortgage REITs

Should Two Harbors Investment’s (TWO) 2025 Earnings Swing From Profit to Loss Require Investor Action?

Two Harbors Investment Corp. recently reported its fourth-quarter and full-year 2025 results, swinging from net income of US$276.73 million in the prior-year quarter to net income of US$11.72 million, and from full-year net income of US$298.17 million to a net loss of US$454.3 million. This reversal also showed up at the per-share level, with earnings from continuing operations turning into basic and diluted losses of US$0.02 for the quarter and US$4.88 for the year, highlighting a sharp...
XTRA:SRT3
XTRA:SRT3Life Sciences

Sartorius Q4 Margin Miss Shifts Focus To Earnings Quality And Mix

Sartorius (XTRA:SRT3) reported Q4 results that missed expectations, with pressure on margins. Management issued cautious guidance, highlighting a focus on margin recovery. The company plans to prioritize higher value product rollouts as part of its response. These updates signal a potential inflection point in how Sartorius balances growth, profitability, and product mix. Sartorius, a supplier of equipment and solutions for the biopharma and life sciences industry, operates within long term...
NYSE:ABR
NYSE:ABRMortgage REITs

Is Arbor Realty Trust (ABR) Pricing Reflect Long-Term Value After Steep Multi-Year Share Price Slide

If you are wondering whether Arbor Realty Trust is priced attractively right now, this article will walk you through what the current share price might be implying about its value. The stock last closed at US$7.80, with returns of 1.3% over the past week, a 3.3% decline over the past month, a 1.9% decline year to date, and a 35.9% decline over the past year, as well as a 23.3% decline over three years and a 13.0% decline over five years. Recent coverage of Arbor Realty Trust has focused on...
SWX:GIVN
SWX:GIVNChemicals

Givaudan (SWX:GIVN) Valuation Check After Full Year Results And Dividend Announcement

Why Givaudan’s latest earnings and dividend matter for shareholders Givaudan (SWX:GIVN) has put fresh numbers on the table, pairing its full year 2025 earnings release with an annual dividend announcement that gives investors clearer insight into both cash returns and recent business performance. See our latest analysis for Givaudan. The latest earnings and dividend announcement comes after a mixed share price stretch, with a 7 day share price return of 3.58% but a 1 year total shareholder...
NYSEAM:TMP
NYSEAM:TMPBanks

Why Tompkins Financial (TMP) Is Up 5.3% After Stronger 2025 Earnings And Dividend Increase

Tompkins Financial Corporation reported past fourth-quarter and full-year 2025 results showing higher net interest income and net income versus 2024, with basic earnings per share from continuing operations rising to US$6.74 for the quarter and US$11.30 for the year. Alongside these stronger earnings, the company raised its regular quarterly dividend to US$0.67 per share and completed a small share repurchase program, highlighting a continued focus on returning cash to shareholders despite...
NYSE:PGR
NYSE:PGRInsurance

Progressive (PGR) Valuation Check As Strong Earnings Meet Softer Analyst Outlook And Sell Rating

Why Progressive’s earnings and analyst sentiment are pulling investor focus Progressive (PGR) has moved into the spotlight after a strong full year 2025 earnings report coincided with softer analyst expectations for the current quarter and fiscal year, along with a Zacks Rank #4 (Sell). That mix of solid reported results and more cautious forward estimates is creating a gap between what the company just delivered and what some analysts now project. This difference is what many investors are...
NYSE:BRBR
NYSE:BRBRPersonal Products

A Look At BellRing Brands (BRBR) Valuation After Inventory Stockpiling Disclosure And Legal Challenges

BellRing Brands (BRBR) is under pressure after acknowledging that earlier strong sales were tied to retailers stockpiling inventory rather than underlying consumer demand, a disclosure now central to multiple securities class action investigations. See our latest analysis for BellRing Brands. The legal fallout from BellRing's inventory disclosure has gone hand in hand with sharp market repricing, with a 7 day share price return of 21.51% decline and a 1 year total shareholder return of 74.50%...
SWX:VONN
SWX:VONNCapital Markets

Vontobel Holding (SWX:VONN) Margin Improvement To 19.6% Tests Long Term Bearish Earnings Narrative

Vontobel Holding (SWX:VONN) closed FY 2025 with second half revenue of CHF 741.7 million and basic EPS of CHF 2.94, while trailing 12 month revenue came in at CHF 1.43 billion with basic EPS of CHF 4.99, setting a clear benchmark for the latest reporting stretch. The company has seen revenue move from CHF 694.3 million and basic EPS of CHF 2.44 in 2024’s second half to CHF 741.7 million and CHF 2.94 respectively in 2025’s second half, with trailing net income of CHF 280.1 million framing a...
TSX:FTS
TSX:FTSElectric Utilities

Assessing Fortis (TSX:FTS) Valuation After Recent Share Price Softness And Ongoing Grid Investment Plans

What Fortis Stock’s Recent Performance Tells You Fortis (TSX:FTS) has drawn attention after a recent 2% one day decline, even as its share price shows positive returns over the past week, month, past 3 months and year. See our latest analysis for Fortis. The recent 2% one day share price decline to around CA$73.74 comes after a period of steady share price gains, with a 7 day share price return of 1.57% and a 30 day share price return of 2.95%, while the 1 year total shareholder return of...
NYSE:LLY
NYSE:LLYPharmaceuticals

Is Eli Lilly (LLY) Still Attractive After Strong Multi‑Year Share Price Gains?

If you are wondering whether Eli Lilly's current share price still makes sense for new money, the key question is how that price lines up against its underlying value. The stock most recently closed at US$1,058.18, with returns of 2.0% over the last 7 days, a 0.5% decline over 30 days, a 2.1% decline year to date, 21.4% over 1 year, 214.0% over 3 years and a very large gain over 5 years. Recent news coverage around Eli Lilly has largely focused on its position in major treatment areas and...
NasdaqGS:AAPL
NasdaqGS:AAPLTech

Assessing Apple (AAPL) Valuation After Strong Q1 Earnings And New AI Partnerships

Apple (AAPL) just delivered a busy start to 2026, with record first quarter results, fresh AI partnerships and regulatory clarity in Europe, giving investors several new data points to assess the stock. See our latest analysis for Apple. Those earnings and AI headlines arrive after a strong run in the stock, with Apple’s 7 day share price return of 7.18% and 30 day return of 7.23% helping push the 1 year total shareholder return to 22.73% and 5 year total shareholder return to 110.74%. This...